August 2026 Trial Snapshot
💻
Best viewed on desktop
The Lupus trial snapshot includes an interactive map and data tables that work best on a larger screen.
Read the Lupus research guide →Active sponsors
Trials
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
Neutrophil Extracellular Traps and Lupus Nephritis
Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis
Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus
Showing trials with activity in the past 30 days. See the full Lupus research landscape →
Recently completed · awaiting results
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
Condition guide
Lupus — the full picture
Research landscape, trial types, and what eligibility typically looks like — written for patients but useful for everyone.
Monthly digest
Get this brief every month
We’ll email you the Lupusbrief as soon as it’s published — no login required.
Coming soon